C5 and paroxysmal nocturnal hemoglobinuria: It was reported that thrombosis in PNH patients could be resistant to the anticoagulant treatment, The anti-C5 humanized monoclonal antibody, such as ravulizumab, could be applied to prevent recurrent thrombosis (21).